Press release
Investigation announced for Long-Term Investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) over potential Wrongdoing

An investigation on behalf of current long term investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) shares.
Investors who are current long term investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: RVNC stocks follows a lawsuit filed against Revance Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: RVNC stocks, concerns whether certain Revance Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Middle District of Tennessee the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that Revance was in material breach of the Distribution Agreement, thst the foregoing subjected the Company to an increased risk of litigation, as well as monetary and reputational harm, that all the foregoing increased the risk that the Tender Offer would be delayed and/or amended, and that as a result, the Company's public statements were materially false and misleading at all relevant times
Those who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) over potential Wrongdoing here
News-ID: 3986912 • Views: …
More Releases from Shareholders Foundation, Inc.

Investors who hold shares of e.l.f. Beauty, Inc. (NYSE: ELF) Long Term should co …
An investigation was announced for long-term investors in shares of e.l.f. Beauty, Inc. (NYSE: ELF) concerning potential breaches of fiduciary duties by certain directors of e.l.f. Beauty, Inc.
Investors who are current long term investors in e.l.f. Beauty, Inc. (NYSE: ELF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…

Lawsuit filed for Investors who lost money with shares of UnitedHealth Group Inc …
An investor, who purchased shares of UnitedHealth Group Incorporated (NYSE: UNH), filed a lawsuit over alleged violations of Federal Securities Laws by UnitedHealth Group Incorporated in connection with certain allegedly false and misleading statements.
Investors who purchased shares of UnitedHealth Group Incorporated (NYSE: UNH) have certain options and for certain investors are short and strict deadlines running. Deadline: July 7, 2025. NYSE: UNH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…

Investigation announced for Long-Term Investors in shares of Skyworks Solutions, …
An investigation was announced for current long-term investors in shares of Skyworks Solutions, Inc. (NASDAQ: SWKS) concerning potential breaches of fiduciary duties by certain directors of Skyworks Solutions, Inc.
Investors who are current long term investors in Skyworks Solutions, Inc. (NASDAQ: SWKS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…

Perpetua Resources Corp. (NASDAQ: PPTA) Investor Alert: Deadline in Lawsuit on M …
A deadline is coming up on May 20, 2025 in the lawsuit filed for certain investors of Perpetua Resources Corp. (NASDAQ: PPTA) over alleged securities laws violations by Perpetua Resources Corp.
Investors who purchased shares of Perpetua Resources Corp. (NASDAQ: PPTA) have certain options and there are strict and short deadlines running. Deadline: May 20, 2025. Perpetua Resources Corp. (NASDAQ: PPTA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
More Releases for Revance
Investigation announced for Investors in Revance Therapeutics, Inc. (NASDAQ: RVN …
An investigation was announced for long-term investors in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) concerning potential breaches of fiduciary duties by certain directors and officers of Revance Therapeutics, Inc.
Investors who are current long term investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Deadline on Feb. 8th coming up in Lawsuit for INvestros in Revance Therapeutics, …
A deadline is coming up on February 8, 2022 in the lawsuit filed for certain investors of Revance Therapeutics, Inc. (NASDAQ: RVNC) over alleged securities laws violations by Revance Therapeutics, Inc.
Investors who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) have certain options and there are strict and short deadlines running. Deadline: February 8, 2022. NASDAQ: RVNC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors in shares of Revance Therapeutics, Inc. (NASDAQ: RVN …
An investor in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) filed a lawsuit over alleged Securities Laws violations by Revance Therapeutics, Inc.
Investors who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) have certain options and for certain investors are short and strict deadlines running. Deadline: February 8, 2022. NASDAQ: RVNC investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Newark, CA based Revance Therapeutics, Inc.,…
Investigation for Investors in NASDAQ: RVNC shares over possible Wrongdoing at R …
Certain directors of Revance Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Revance Therapeutics, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Newark, CA based Revance Therapeutics,…
Palmer Hyperhidrosis Treatment Market Research Report (2021-2027): Key Trends an …
Hyperhidrosis is a disorder that results in excessive sweating of palms, soles, or underarms. Palmer hyperhidrosis is excessive and uncontrollable hand sweating and is the most common type of hyperhidrosis. The sweating may range from mild to severe. Market Snapshot A recently published report by QY Research, titled “Global Palmer Hyperhidrosis Treatment Market Size, Status and Forecast 2022” gives an overview of the overall Palmer Hyperhidrosis Treatment market. This section…
Investigation announced for Investors in shares of Revance Therapeutics, Inc. (N …
An investigation was announced over potential securities laws violations by Revance Therapeutics, Inc. in connection with certain financial statements.
Investors who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Revance Therapeutics, Inc. regarding its business, its prospects and its operations were…